Categories
Featured Investing Stock Market News Stock Market Today

Stock Market Today: Dow Jones, S&P 500 Edged Higher On PPI Reading; Delta Air Lines (DAL) Up After Earnings Beat

Markets ticked higher after yet another key inflation report was released today.

Stock Market Today Mid-Morning Updates

On Wednesday, the Dow Jones Industrial Average is up by 40 points after the release of the producer price index (PPI) for March. The index indicates that the prices of goods and services producers receive rose at the fastest pace since records have been kept, the Bureau of Labor Statistics reported on Wednesday. Diving in, it increased by 11.2% from a year ago. On a monthly basis, it increased 1.4%, above the 1.1% estimates and also setting a new record. The PPI is a forward-looking inflation measure that tracks the prices in the pipeline for goods and services. These are prices that will eventually reach consumers.

Today, shares of Bed Bath & Beyond (NASDAQ: BBBY) were down by over 8% after reporting an adjusted quarterly loss of $0.92 per share, compared with consensus expectations of a $0.03 profit per share. Also, asset management firm BlackRock (NYSE: BLK) posted an adjusted quarterly profit of $9.52 per share compared with the consensus estimate of $8.75. Revenues are also in line with estimates. 

Among the Dow Jones leaders, shares of Apple (NASDAQ: AAPL) are up by 0.23% today while Microsoft (NASDAQ: MSFT) is also up by 0.38%. Meanwhile, Disney (NYSE: DIS) and Nike (NYSE: NKE) are trading higher on Wednesday. Among the Dow financial leaders, Visa (NYSE: V) is down by 0.55% while JPMorgan Chase (NYSE: JPM) is also down by 2.19%.

Shares of EV leader Tesla (NASDAQ: TSLA) are up by 0.19% on Wednesday. Rival EV companies like Rivian (NASDAQ: RIVN) are up by 0.60%. Lucid Group (NASDAQ: LCID) however is down by 0.63% today. Chinese EV leaders like Nio (NYSE: NIO) and Xpeng Motors (NYSE: XPEV) opened higher today.

Dow Jones Today: Mortgage Demand Outlook Lowered and Treasury Yields Also Decline

Following the stock market opening on Wednesday, the S&P 500, Dow, and Nasdaq are trading higher at 0.09%, 0.14%, and 0.54% respectively. Among exchange-traded funds, the Nasdaq 100 tracker Invesco QQQ Trust (NASDAQ: QQQ) is up by 0.67% while the SPDR S&P 500 ETF (NYSEARCA: SPY) is also up by 0.14%. 

The 10-year Treasury yield dropped to 2.67% today. Before the release of the Consumer Price Index on Tuesday however, it had reached its highest point since December 2018, topping 2.82%. Mortgage bankers also lowered their demand outlook for 2022. This comes as the steep increases in rates are further stressing the affordability of the housing market. Diving in, the Mortgage Bankers Association expects overall mortgage originations to be $2.58 trillion this year, after previously stating $2.61 trillion. This would represent a decline of over 30% when compared with 2021.

Recently, President Joe Biden called Russia’s actions in Ukraine a genocide, offering the characterization for the first time since the war began. This comes as the U.S. is expected to offer an additional $750 million in military aid to Ukraine. The announcement for military aid could come as soon as today.

[Read More] Top Stock Market News For Today April 13, 2022

Delta Air Lines Stock Jumps Following Better-Than-Expected Earnings And Ambitious Earnings Outlook

Among the top gainers in the stock market today would be Delta Air Lines (NYSE: DAL). By and large, this major airline operator is in the spotlight now because of its latest financial update. Overall, DAL raked in a total revenue of $9.35 billion for the quarter. This tops consensus forecasts of $8.92 billion. Moreover, the company is also looking at a loss per share of $1.23, better than analyst estimates of a $1.27 loss. Not to mention, the company’s sales for the quarter are also 11% lower than 2019 levels. With growing revenue and narrowing losses, some would argue that DAL is on the upswing now.

Additionally, another reason for the current attention around DAL stock now would be the company’s outlook for the second quarter. Notably, CEO Ed Bastian notes that the company is looking to return to profitability for the June 2022 quarter. The reason for this could be DAL’s latest booking figures in March. Bastian highlights that the company saw its highest monthly bookings of all time in March. He argues that this alongside consumers increasingly prioritizing travel despite inflation could serve as growth catalysts for DAL. 

On top of all that, the company is expecting its revenue for the current quarter to outpace pre-pandemic levels as well. To achieve this, DAL is already preparing to ramp up its operations to 84% of its 2019 capacity. As a result of these positive developments, DAL stock is now gaining by over 4% at today’s opening bell.

Source: TradingView

[Read More] Best Stocks To Invest In Right Now? 3 Consumer Staples Stocks To Know

Sierra Oncology Stock Pops After News Of $1.9 Billion GSK Takeover 

Sierra Oncology (NASDAQ: SRRA) is in the news today following an announcement from GlaxoSmithKline (NYSE: GSK). In detail, the global health care giant is acquiring Sierra Oncology for a whopping $1.9 billion. This would value the oncology biotech firm at about $55 per share. Because of all this, SRRA stock is now gaining by over 37% today. Through the current purchase, GSK is getting access to Sierra’s pipeline of targeted cancer therapies. The likes of which include the company’s differentiated momelotinib that “has the potential to address the critical unmet medical needs of myelofibrosis patients with anaemia.

Furthermore, GSK notes that momelotinib synergizes well with its existing work in the field of haematology. By Sierra’s current estimates, we could see a U.S. regulatory submission by the second quarter of 2022. In turn, the company is also eyeing an EU submission by the second half of the year. Weighing in on this decision is GSK’s CCO, Luke Miels. He says, “With this proposed acquisition, we have the opportunity to potentially bring meaningful new benefits to patients and further strengthen our portfolio of specialty medicines.” After considering all of this, GSK would be bolstering its oncology division signficantly. As such, it would not surprise me to see investors eyeing both GSK stock and SRRA stock now.

Source: TradingView

If you enjoyed this article and you’re interested in learning how to trade so you can have the best chance to profit consistently then you need to checkout this YouTube channel. CLICK HERE RIGHT NOW!!

By Brett David

Brett David is a digital marketing and finance professional for nearly 10 years now and a contributing author for StockMarket.com. His passion for digital marketing and the stock market began after graduating with a B.S.B.A in business administration and finance. After completing college, he went on to becoming an entrepreneur in the marketing and finance space, which led to becoming a contributor to outlets such as ThriveGlobal.com, MarijuanaStocks.com, MarketingAgency.com and SearchEngineWatch.com.

Brett loves the ability to deliver to his readers engaging and educational content that can be easily consumed by the reader. He enjoys writing about a wide variety of companies ranging from blue-chip stocks to the undervalued small and micro cap stocks. His favorite stock market sectors today to write about are: Tech, Cannabis, Mining, Biotech, and TMT.

Brett has worked with hundreds of publicly traded companies on increasing their digital footprint and corporate outreach since 2013.

You can find Brett most of time digging through corporate filings conducting fundamental analysis or at an industry conference looking for the next big trend or company to hit the street. His digital marketing experience gives a competitive edge over other contributing authors by allowing him to see and analyze trends faster than the next person.

Brett, a South Florida native, enjoys spending time with his wife and son outdoors, and is an avid basketball and MMA fan.

Subscribe
Notify of
0 Comments
Inline Feedbacks
View all comments